SDGR vs RXRX
SDGR 与 RXRX 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | SDGRSchrodinger, Inc. | RXRXRECURSION PHARMACEUTICALS, INC. |
|---|---|---|
| 营收 | $254.91M(TTM) | — |
| 营收同比增长 | 23.3% | 26.9% |
| 净利润 | -$103.48M(TTM) | — |
| 净利同比增长 | 44.8% | -39.1% |
| 每股收益(稀释) | $-1.40(TTM) | — |
| 息税前利润率 | -65.2% | -867.9% |
| 净资产收益率 | -32.9% | -62.9% |
| 投入资本回报率 | — | -174.7% |
| 一年总回报 | -21.6% | -43.8% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:SDGR vs RXRX
| 指标 | SDGR | RXRX |
|---|---|---|
| 期末价值 | $2.0K | $1.0K |
| 总回报 | -80.4% | -89.8% |
| 年化收益 (CAGR) | -26.5% | -35.1% |
| 波动率 | 62.4% | 92.9% |
| 夏普比率 | -0.25 | -0.07 |
| 索提诺比率 | -0.37 | -0.10 |
| 最大回撤 | -86.0% | -93.1% |
基于 1330 个共同交易日,2021-04-16 → 2026-08-03 · 无风险利率 3.83%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)